FDA Inspection 1072981 — LifeServe Blood Center
The FDA completed an inspection of LifeServe Blood Center on October 23, 2018 in Marshalltown, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 23, 2018
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Marshalltown, IA (United States)